Complex host genetic susceptibility to Staphylococcus aureus infections

Trends in Microbiology

Volumn 23, Issue 9, 2015, Pages 529-536

  Shukla, Sanjay K ^a   Rose, Warren ^b   Schrodi, Steven J ^a  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bacteremia; Genome wide association study; Host genetic susceptibility; Immune response; Polymorphisms; Staphylococcus aureus

Indexed keywords

BETA DEFENSIN 1; C REACTIVE PROTEIN; INTERLEUKIN 4; VITAMIN D RECEPTOR;

BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; CDON GENE; CRP GENE; CYTOKINE PRODUCTION; DAPK3 GENE; DEFB1 GENE; DISEASE SEVERITY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HOST SUSCEPTIBILITY; IL4 GENE; INFECTION RISK; NONHUMAN; NR3C1 GENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VDR GENE; XRN1 GENE; ANIMAL; CROSS INFECTION; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER STATE; CROSS INFECTION; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84940461787     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2015.05.008     Document Type: Review

References (61)

1. Falugi F., et al. Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio 2013, 4:e00575-e613.
2. van Belkum A., et al. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 2009, 199:1820-1826.
3. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
4. Shukla S.K. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin. Med. Res. 2005, 3:57-60.
5. Wertheim H.F., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5:751-762.
6. Marquet S., et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 1996, 14:181-184.
7. Smith P., et al. Schistosoma mansoni secretes a chemokine binding protein with anti-inflammatory activity. J. Exp. Med. 2005, 202:1319-1325.
8. Franke A., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
9. Anderson C.A., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43:246-252.
10. Liu J.Z., et al. UK Primary Biliary Cirrhosis (PBC) Consortium; Wellcome Trust Case Control Consortium 3. 2012. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 2012, 44:1137-1141.
11. de Bakker P.I., Telenti A. Infectious diseases not immune to genome-wide association. Nat. Genet. 2010, 42:731-732.
12. Kisich K.O., et al. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J. Invest. Dermatol. 2007, 127:2368-2380.
13. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
14. Fournier B., Philpott D.J. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 2005, 18:521-540.
15. von Köckritz-Blickwede M., et al. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am. J. Pathol. 2008, 173:1657-1668.
16. Nippe N., et al. Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response. J. Immunol. 2011, 193:1090-1099.
17. Myles I.A., et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat. Immunol. 2013, 14:804-811.
18. Krishna S., Miller L.S. Host-pathogen interactions between the skin and Staphylococcus aureus. Curr. Opin. Microbiol. 2012, 15:28-35.
19. Takeuchi O., et al. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 2000, 165:5392-5396.
20. Schmaler M., et al. T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. J. Immunol. 2011, 186:443-452.
21. Deshmukh H.S., et al. Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect. Immun. 2009, 77:1376-1382.
22. Shi Y., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res. 2006, 16:126-133.
23. Ahn S.H., et al. Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses. PLoS Pathog. 2010, 6:e1001088.
24. Yan Q., et al. Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis. PLoS Pathog. 2014, 10:e1004149.
25. Berube B.J., Bubeck-Wardenburg J. Staphylococcus aureus α11-toxin: nearly a century of intrigue. Toxins (Basel) 2013, 5:1140-1166.
26. Inoshima N., et al. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 2012, 132:1513-1516.
27. Andersen P.S., et al. Influence of host genetics and environment on nasal carriage of Staphylococcus aureus in Danish middle-aged and elderly twins. J. Infect. Dis. 2012, 206:1178-1184.
28. Ruimy R., et al. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans?. J. Infect. Dis. 2010, 202:924-934.
29. Emonts M., et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 2008, 197:1244-1253.
30. Nurjadi D., et al. Impaired β-defensin expression in human skin links DEFB1 promoter polymorphisms with persistent Staphylococcus aureus nasal carriage. J. Infect. Dis. 2013, 207:666-674.
31. van den Akker E.L., et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J. Infect. Dis. 2006, 194:814-818.
32. Messaritakis I., et al. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 2 diabetes. Clin. Microbiol. Infect. 2014, 20:920-925.
33. Ye Z., et al. Genome wide association study of SNP-, gene-, and pathway-based approaches to identify genes influencing susceptibility to Staphylococcus aureus Infection. Front. Genet. 2014, 5:125.
34. Nelson C.L., et al. A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a health care setting. BMC Infect. Dis. 2014, 14:83.
35. Cormier C., et al. A pooling-based genomewide association study identified genetic variants associated with Staphylococcus aureus colonization in chronic rhinosinusitis patients. Int. Forum Allergy Rhinol. 2014, 4:207-215.
36. Nagarajan V.K., et al. XRN 5'-3' exoribonucleases: structure, mechanisms and functions. Biochem. Biophys. Acta 2013, 1829:590-603.
37. Wu Y., et al. Link of Dlk/ZIP kinase to cell apoptosis and tumor suppression. Biochem. Biophys. Res. Commun. 2010, 392:510-515.
38. Nehru V., et al. Interaction of RhoD and ZIP kinase modulates actin filament assembly and focal adhesion dynamics. Biochem. Biophys. Res. Commun. 2013, 433:163-169.
39. Chong Y.P., et al. Association of mannose-binding lectin 2 gene polymorphisms with persistent Staphylococcus aureus bacteremia. PLoS ONE 2014, 9:e89139.
40. Fowler T., et al. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur. J. Cell Biol. 2000, 79:672-679.
41. Garlanda C., et al. The interleukin-1 family: back to the future. Immunity 2013, 39:1003-1018.
42. Ghosh C., Bishayi B. Toll-like receptor 2 and 6 interdependency in the erosive stage of Staphylococcus aureus induced septic arthritis mediated by IFN-g and IL-6 - A possible involvement of IL-17 in the progression of the disease. Immunobiology 2015, 220:910-923.
43. Rose W.E., et al. Elevated serum interleukin-10 (IL-10) at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J. Infect. Dis. 2012, 206:1604-1611.
44. Komatsu K., et al. Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nat. Commun. 2013, 4:1684.
45. Dupont N., et al. Neutral lipid stores and lipase PNPLA5 contribute to autophagosome biogenesis. Curr. Biol. 2014, 24:609-620.
46. Kehl-Fie T.E., Skaar E.P. Nutritional immunity beyond iron: a role for manganese and zinc. Curr. Opin. Chem. Biol. 2010, 14:218-224.
47. Wakabayashi Y., et al. Bcl11b is required for differentiation and survival of alpha beta T lymphocytes. Nat. Immunol. 2003, 4:533-539.
48. Jansen K.U., et al. Vaccine review: "Staphylococcus aureus vaccines: Problems and prospects.". Vaccine 2013, 31:2723-2730.
49. Grimbacher B., et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N. Engl. J. Med. 1999, 340:692-702.
50. Minegishi Y., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper IgE syndrome. Nature 2007, 448:1058-1062.
51. Holland S.M., et al. STAT3 mutations in the Hyper-IgE syndrome. N. Engl. J. Med. 2007, 357:1608-1619.
52. Zhang Q., et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 2009, 361:2046-2055.
53. Minegishi Y., et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006, 25:745-755.
54. Etzioni A., Harlan J.M. Cell adhesion and leukocyte adhesion defects. Primary Immunodeficiency Diseases: a Molecular and Genetic Approach 1999, 375-388. Oxford University Press. H.D. Ochs (Ed.).
55. Tone Y., et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood 2007, 109:1182-1184.
56. Lubke T., et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 2001, 28:73-76.
57. Svensson L., et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat. Med. 2009, 15:306-312.
58. Blaydon D.C., et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 2011, 365:1502-1508.
59. Von Bermuth H., et al. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur. J. Immunol. 2010, 42:3126-3135.
60. Amagai M., et al. Toxin in bullous impetigo and staphylococcal scaled-skin syndrome targets desmoglein 1. Nat. Med. 2000, 6:1275-1277.
61. Nagasaka T., et al. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. J. Clin. Invest. 2004, 114:1484-1492.